Kristen Reeder

Dr. Reeder received her Ph.D. in Biomedical Sciences in 2017 from the University of Alabama at Birmingham with a concentration in Immunology. Kristen’s dissertation examined the role of common gamma-chain cytokines in Aspergillus fumigatus lung diseases including: models of invasive aspergillosis and fungal associated asthma.

She accepted a post-doctoral training position with Dr. Casey Weaver’s lab at UAB in 2018. There she studied the effects of IL-2 on the Th17/Th22 developmental pathways in a gut model of Citrobacter rodentium infection. In 2020, Kristen joined Dr. James Crowe’s lab at Vanderbilt Vaccine Center as a staff scientist.